Literature DB >> 23627816

Validation of self-reported cannabis dose and potency: an ecological study.

Peggy van der Pol1, Nienke Liebregts, Ron de Graaf, Dirk J Korf, Wim van den Brink, Margriet van Laar.   

Abstract

AIMS: To assess the reliability and validity of self-reported cannabis dose and potency measures.
DESIGN: Cross-sectional study comparing self-reports with objective measures of amount of cannabis and delta-9-tetrahydrocannabinol (THC) concentration.
SETTING: Ecological study with assessments at participants' homes or in a coffee shop. PARTICIPANTS: Young adult frequent cannabis users (n = 106) from the Dutch Cannabis Dependence (CanDep) study. MEASUREMENTS: The objectively measured amount of cannabis per joint (dose in grams) was compared with self-reported estimates using a prompt card and average number of joints made from 1 g of cannabis. In addition, objectively assessed THC concentration in the participant's cannabis was compared with self-reported level of intoxication, subjective estimate of cannabis potency and price per gram of cannabis.
FINDINGS: Objective estimates of doses per joint (0.07-0.88 g/joint) and cannabis potency (1.1-24.7%) varied widely. Self-reported measures of dose were imprecise, but at group level, average dose per joint was estimated accurately with the number of joints made from 1 g [limit of agreement (LOA) = -0.02 g, 95% confidence interval (CI) = -0.29; 0.26], whereas the prompt card resulted in serious underestimation (LOA = 0.14 g, 95% CI = -0.10; 0.37). THC concentration in cannabis was associated with subjective potency ['average' 3.77% (P = 0.002) and '(very) strong' 5.13% more THC (P < 0.001) than '(very) mild' cannabis] and with cannabis price (about 1% increase in THC concentration per euro spent on 1 g of cannabis, P < 0.001), but not with level of intoxication.
CONCLUSIONS: Self-report measures relating to cannabis use appear at best to be associated weakly with objective measures. Of the self-report measures, number of joints per gram, cannabis price and subjective potency have at least some validity.
© 2013 Society for the Study of Addiction.

Entities:  

Keywords:  Dose; THC; potency; quantity; self-report; validation

Mesh:

Substances:

Year:  2013        PMID: 23627816     DOI: 10.1111/add.12226

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  22 in total

1.  The potential impact of cannabis legalization on the development of cannabis use disorders.

Authors:  Alan J Budney; Jacob T Borodovsky
Journal:  Prev Med       Date:  2017-06-28       Impact factor: 4.018

Review 2.  The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

Authors:  Mallory J E Loflin; Brian D Kiluk; Marilyn A Huestis; Will M Aklin; Alan J Budney; Kathleen M Carroll; Deepak Cyril D'Souza; Robert H Dworkin; Kevin M Gray; Deborah S Hasin; Dustin C Lee; Bernard Le Foll; Frances R Levin; Joshua A Lile; Barbara J Mason; Aimee L McRae-Clark; Ivan Montoya; Erica N Peters; Tatiana Ramey; Dennis C Turk; Ryan Vandrey; Roger D Weiss; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2020-04-26       Impact factor: 4.492

3.  Daily patterns of substance use and violence among a high-risk urban emerging adult sample: Results from the Flint Youth Injury Study.

Authors:  Patrick M Carter; James A Cranford; Anne Buu; Maureen A Walton; Marc A Zimmerman; Jason Goldstick; Quyen Ngo; Rebecca M Cunningham
Journal:  Addict Behav       Date:  2019-09-10       Impact factor: 3.913

4.  Daily associations between cannabis motives and consumption in emerging adults.

Authors:  Erin E Bonar; Jason E Goldstick; R Lorraine Collins; James A Cranford; Rebecca M Cunningham; Stephen T Chermack; Frederic C Blow; Maureen A Walton
Journal:  Drug Alcohol Depend       Date:  2017-06-15       Impact factor: 4.492

5.  The prevalence and incidence of medicinal cannabis on prescription in The Netherlands.

Authors:  Arno Hazekamp; Eibert R Heerdink
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

6.  Cannabis use during methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis.

Authors:  Heather McBrien; Candice Luo; Nitika Sanger; Laura Zielinski; Meha Bhatt; Xi Ming Zhu; David C Marsh; Lehana Thabane; Zainab Samaan
Journal:  CMAJ Open       Date:  2019-11-19

7.  Quantifying cannabis: A field study of marijuana quantity estimation.

Authors:  Mark A Prince; Bradley T Conner; Matthew R Pearson
Journal:  Psychol Addict Behav       Date:  2018-05-17

8.  The Effects of Acute Cannabis Use on Nontraffic Injury Risk: Reviewing the Available Literature and Identifying Ways Forward.

Authors:  Gabriel Andreuccetti; Yu Ye; Jaewook Kang; Rachael Korcha; Jane A Witbrodt; Heraclito B Carvalho; Cheryl J Cherpitel
Journal:  Contemp Drug Probl       Date:  2017-06-30

9.  International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.

Authors:  Simon Haroutounian; Lars Arendt-Nielsen; Joletta Belton; Fiona M Blyth; Louisa Degenhardt; Marta Di Forti; Christopher Eccleston; David P Finn; Nanna B Finnerup; Emma Fisher; Alexandra E Fogarty; Ian Gilron; Andrea G Hohmann; Eija Kalso; Elliot Krane; Mohammed Mohiuddin; R Andrew Moore; Michael Rowbotham; Nadia Soliman; Mark Wallace; Nantthasorn Zinboonyahgoon; Andrew S C Rice
Journal:  Pain       Date:  2021-07-01       Impact factor: 6.961

10.  Supporting Future Cannabis Policy - Developing a Standard Joint Unit: A Brief Back-Casting Exercise.

Authors:  Hugo López-Pelayo; Silvia Matrai; Mercè Balcells-Olivero; Eugènia Campeny; Fleur Braddick; Matthijs G Bossong; Olga S Cruz; Paolo Deluca; Geert Dom; Daniel Feingold; Tom P Freeman; Pablo Guzman; Chandni Hindocha; Brian C Kelly; Nienke Liebregts; Valentina Lorenzetti; Jakob Manthey; João Matias; Clara Oliveras; Maria Teresa Pons; Jürgen Rehm; Moritz Rosenkranz; Zoe Swithenbank; Luc van Deurse; Julian Vicente; Mike Vuolo; Marcin Wojnar; Antoni Gual
Journal:  Front Psychiatry       Date:  2021-05-20       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.